The prognostic value of cytokine dynamics at Epstein-Barr viral infectious mononucleosis, depending on the age of a child
https://doi.org/10.25789/YMJ.2019.65.02
Abstract
A comprehensive immunological examination of children of different age groups with Epstein-Barr-viral infectious mononucleosis was carried out in order to identify the prognostic value of the cytokine dynamics.
It was revealed that changes in the cytokine profile in 3-6 years old children can be considered as a factor explaining the frequent reactivation of EBV in preschool children. A complex immunological response in 12–17 years old children can be considered the most favorable response to the EBV elimination. The immune response of 7-11 years old children was in an intermediate position.
About the Authors
E. A. KashubaRussian Federation
Kashuba Ehduard Alekseevich – PhD, Chief of the Department of infectious diseases
Tyumen
M. V. Antonova
Russian Federation
Antonova Mariya Vladimirovna - Teaching Assistant, the Department of infectious diseases
Tyumen
T. G. Drozdova
Russian Federation
Drozdova Tatyana Georgievna – Candidate of Medical Sciences, the Department of infectious diseases
Tyumen
L. V. Hanipova
Russian Federation
Hanipova Lyudmila Vyacheslavovna - Candidate of Medical Sciences, the Department of infectious diseases
Tyumen
O. A. Ljubimceva
Russian Federation
Lyubimceva Oksana Anatolevna - Candidate of Medical Sciences, the Department of infectious diseases
Tyumen
N. V. Ogoshkova
Russian Federation
Ogoshkova Natalya Vladimirovna - Candidate of Medical Sciences, the Department of infectious diseases
Tyumen
Ju. S. Chehova
Russian Federation
Chehova Julia Sergeevna- Teaching Assistant, the Department of infectious diseases
Tyumen
References
1. Barycheva L.Yu. Factors and mechanisms of immunosuppression in Epstein-Barr viral infection / L.Yu. Barycheva, M.V. Golubeva, A.V. Volkova // Childhood infections. – 2014. – V.2. – P.28-33.
2. Bolevich S.B. Biotherapy of immune-mediated inflammatory diseases: a guide for physicians / S.B. Bolevich, G.G. Sinelnikov // M.: MIA. – 2012. – 128 р.
3. Dyachkovskaya P.S. Herpetic infection / P.S. Dyachkovskaya // Ecology and human health in the North. Collection of materials of the IV-th Congress with international participation.-Russia, Yakutsk, North-Eastern state university of M.K. Ammosov. 4-7 December, 2013. – P.201-204.
4. Ivanova O.N. Treatment of chronic infection of Epstein-Barr virus in children / O.N. Ivanova // Yakut medical journal. – 2017. – V.60, №4. – P.63-64.
5. Kramarev S.A. Epstein-Barr viral infection in children / S.A. Kramarev, O.V. Vygovskaya // Actual infection. – 2013. – V.1. – №1. – P.73-78.
6. Nagaev B.S. Cytokine status in patients with herpesvirus infections / B.S. Nagaev, Z.A. Kambachkova // Infectious disease. – 2011. – V.1. – P.19-22.
7. Simovanyan E.N The role of a «cytokine» environment in the immunopathogenesis of infectious mononucleosis Epstein-Barr virus etiology / E.N. Simovanyan, G.G. Harseeva, M.A. Kim // Modern trends in the development of science and technology. – 2016. – P.32-37.
8. Lam J.K.P. Emergence of CD4+ and CD8+ polyfunctional T cell responses against immunodominant lytic and latent EBV antigens in children with primary EBV infection / J.K.P. Lam, K.F. Hui, R.J. Ning [et al.] // Frontiers in microbiology. – 2018. – V.9. – P.416. doi: 10.3389/fmicb.2018.00416
9. Jing L. Extensive CD4 and CD8 T cell cross-reactivity between alphaherpesviruses / L. Jing, K.J. Laing, L. Dong [et al.] // The Journal of Immunology. – 2016. – V.196. – №5. – P.2205-2218. doi:10.4049/jimmunol.1502366
10. Fukuda M. Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2Ainduced cell transformation / M. Fukuda, Y. Kawaguchi // Journal of virology. – 2014. – Vol. 88. – №9. – P.5189-5194. doi:10.1128/JVI.03714-13
11. Marshall N.B. Cytotoxic CD4 T cells in antiviral immunity / N.B. Marshall, S.L. Swain // Journal of biomedicine & biotechnology. – 2011. – V.2011. – P.954602-954602. doi:10.1155/2011/954602
12. Odumade O.A. Progress and problems in understanding and managing primary EpsteinBarr virus infections / O.A. Odumade, K.A. Hogquist, H.H. Balfour // Clinical microbiology reviews. – 2011. – V.24. – №1. – P.193-209. doi:10.1128/CMR.00044-10
13. Systematic analysis of T cell responses specific to the Epstein-Barr virus proteome using ATLAS™ / K.K. Johanna, B. Liu, J. Jacques et al. –2017. – P.78-42.
14. The pathogenesis of Epstein-Barr virus persistent infection / D.A. Thorley-Lawson, J.B. Hawkins, S.I. Tracy [et al.] // Current opinion in virology. – 2013. – V.3. – №3. – P.227-232. doi: 10.1016/j.coviro.2013.04.005 Современные тенденции развития науки и технологий. – 2016. – С. 32-37.
Review
For citations:
Kashuba E.A., Antonova M.V., Drozdova T.G., Hanipova L.V., Ljubimceva O.A., Ogoshkova N.V., Chehova J.S. The prognostic value of cytokine dynamics at Epstein-Barr viral infectious mononucleosis, depending on the age of a child. Yakut Medical Journal. 2019;(1):7-10. https://doi.org/10.25789/YMJ.2019.65.02